It’s all about quality, from source to resource
Swiss Pharma is one of the top Active Pharmaceuticals Ingredient (API) manufacturing companies in the world, and one of the few pharmaceutical companies that is vertically-integrated with a very strong and independent positioning in both the API and the Formulations markets.
Spread over 80,000 sq. meter area, our API manufacturing facility at Nigeria is globally accredited by US FDA, ISO 9001:2008, COFEPRIS, PMDA Japan, EDQM Europe, TGA Australia, WHO Geneva, etc. Recognized as the world’s top API supplier, our cost competitiveness and quality obsession has been a critical influence in driving our profitability and growth in the formulations market as well.
Our diversified portfolio in APIs caters to over 90 countries. At present, we offer over 38 APIs and intermediates across various therapeutic categories – respiratory, diabetology, gastroenterology, pain management (antimigraine), orthopedics and many more.
First-rate Formulations
Our extensive range of finished dosage formulations covers every aspect of human life. Our basket of formulations contains more than 850 products in several forms belonging to 45 therapeutic segments and 12 specialties including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics, immunologicals and oncology. Our formulation business fulfils the need for domestic, regulated, and rest of the world markets.
Our globally accredited, state-of-the-art manufacturing facilities in Nigeriaand Addis Ababa (Ethiopia) produce almost all dosage forms including sterile as well as non-sterile products.